A systematic review involving 12,469 patients indicates that broad-spectrum penicillin-based antibiotics (bs-ab) notably reduce surgical site infections, postoperative pancreatic fistula rates, and mortality compared to standard cephalosporins. Specifically, bs-ab led to a 47% decrease in surgical site infections and a 38% reduction in postoperative pancreatic fistulas. Notably, benefits were enhanced for patients with preoperative biliary […]
Author: STITCHES Newsletter
Automated models enhance competency assessment in laparoscopic surgery
The study demonstrates the development of automated surgical action recognition models, achieving significant accuracy in competency prediction during laparoscopic cholecystectomy. Analysis of the cholec80 dataset revealed that high-competency groups exhibited shorter dissection durations and higher scores on established evaluation metrics. A random forest model achieved 93% accuracy in predicting surgical competency, while a video-masked autoencoder […]
Implementing ERAS can significantly reduce hospital stay lengths
In Ethiopia, adherence to Enhanced Recovery After Surgery (ERAS) guidelines was achieved in 65.2% of cases among 555 patients reviewed. The study revealed that following all five ERAS recommendations led to a remarkable reduction of approximately 5 days in postoperative hospital length of stay (LOS), with early mobilization and prompt feeding showing consistent decreases across […]
Multi-angle suture training enhances laparoscopic skills
A novel multi-angle suture training module significantly improved the laparoscopic skills of surgical residents. In a study involving 36 second-year surgical residents, those trained with the multi-angle module completed laparoscopic end-to-end anastomosis surgeries faster (3375.7 s vs. 4678.2 s) and scored higher in surgical performance (8.2 vs. 6.83) compared to those using traditional training. These […]
Mortality from necrotizing fasciitis sharply increases in the U.S.
Between 2003 and 2020, necrotizing fasciitis (NF) deaths in the U.S. surged by 120.6%, from 824 to 1,842 annually. The age-adjusted mortality rate rose from 0.44 to 0.71 per 100,000 people. Males faced higher mortality overall, with a stark rise post-2015. American Indian or Alaska Native groups reported the highest rates, while regional disparities were […]
Combined imaging improves accuracy for detecting liver metastases
Combining contrast-enhanced CT with MRI significantly boosts the detection of colorectal liver metastases, achieving sensitivity rates of 96.5% compared to 90.6% for MRI alone. Specificity also improved, from 95.3% to 98.3%. Notably, radiologists reported higher diagnostic confidence in 78.8% of cases with the combined approach, up from 64.7% with MRI alone. Additionally, inter-observer agreement reached […]
Immunotherapy shows promise in treating gastric adenocarcinoma
Recent findings reveal that immune checkpoint inhibitors (ICIs) significantly improve treatment outcomes for advanced gastric adenocarcinoma (GAC), especially in patients with specific molecular subtypes such as MSI-H and HER2-positive. Combining ICIs with chemotherapy or targeted therapies enhances efficacy, despite the risk of immune-related adverse events (IRAEs). The study emphasizes the need for effective management strategies […]
New obesity treatments show promise in addressing weight loss challenges
Recent advancements in obesity treatment highlight new pipeline agents that effectively match weight loss results of surgery. Notably, GLP-1 analogs not only reduce weight but also improve obesity-related health issues. However, significant gaps remain, with alternative treatment options needed to address muscle mass loss and energy expenditure decline. Developing novel therapies, including myostatin inhibitors and […]
Immunotherapy shows promise for treating gastrointestinal cancers
Current strategies in immunotherapy for gastrointestinal cancers include immune checkpoint inhibitors, cytokine therapies, and novel approaches like CAR-T therapy. Clinical trials demonstrate significant benefits, although challenges such as immunosuppression and adverse effects remain. Future directions emphasize overcoming barriers, improving patient selection, and developing new treatments, including toll-like receptor-directed therapies. Ongoing research is essential to enhance […]
Prognostic model predicts recurrence and treatment response in HCC
A novel prognostic model utilizing pathological signatures effectively predicts postoperative recurrence risk and sorafenib response in hepatocellular carcinoma (HCC) patients. Analyzed across 287 non-treated patients, the model achieved AUROC values of 0.818 and 0.811 for predicting one and two-year recurrence respectively. Validation with an external cohort confirmed its predictive power. Additionally, it successfully stratified sorafenib-treated […]